Crossmark

Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition

Crossref DOI link: https://doi.org/10.1038/nchembio.2115

Published Online: 2016-07-04

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hohmann, Anja F

Martin, Laetitia J

Minder, Jessica L

Roe, Jae-Seok

Shi, Junwei

Steurer, Steffen

Bader, Gerd

McConnell, Darryl

Pearson, Mark

Gerstberger, Thomas

Gottschamel, Teresa

Thompson, Diane

Suzuki, Yutaka

Koegl, Manfred

Vakoc, Christopher R
License Information

Text and Data Mining valid from 2016-07-04
More Information

Article History

Received: 11 September 2015

Accepted: 6 April 2016

First Online: 4 July 2016

Competing interests

: This study was funded in part via a sponsored research agreement with Boehringer Ingelheim.